Back to results
US 2009/0214562 A1Published application
Combination of a beta-glucan and an egf receptor antagonist for the treatment of cancer and infection
OwnerSteven J. Karelinventor
Life of this patent
Estimating the term…
Abstract
The present invention encompasses a therapeutic combination composition of a β-glucan EGF receptor antagonist. This therapeutic combination composition is useful for the treatment of diseases including proliferative disorders and immune dysfunction.
Claims20
A composition comprising a β-glucan and an EGF receptor antagonist.
A kit comprising a therapeutic dose of a β-glucan and a therapeutic dose of an EGF receptor antagonist either in the same or separate packaging, and instructions for its use.
A pharmaceutical composition comprising a β-glucan and an EGF receptor antagonist in an effective amount to treat one of cancer, infection or both.
Dependencies are inferred from the claim text.